Streetbeat News

Assets

BIG

BKNG

BYD

CMG

DKS

PENN

TSLA

Today's session highlighted significant whale activity in the Consumer Discretionary sector, with notable options trading on stocks like TSLA, BYD, PENN, BIG, JD, DKS, BKNG, and CMG. The trades varied in sentiment from bullish to bearish, involving both call and put options with varying expiration dates and strike prices. This activity could indicate potential trading opportunities based on the whales' movements.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:35 pm

DAL

DDD

JCI

LYFT

MMM

SPCE

UBER

VRT

Today's session highlighted significant options activity for 10 industrials stocks, indicating potential trading opportunities based on whale alerts. These alerts track large transactions, suggesting shifts in market sentiment for stocks like GE, LYFT, JCI, DDD, MMM, BA, VRT, SPCE, UBER, and DAL. The activity varied from bullish to bearish sentiments across different expiration dates and strike prices, reflecting diverse market expectations.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:35 pm

AAPL

AMD

NVDA

PLTR

Today's session highlighted significant whale activity in the options market for 10 Information Technology stocks, indicating potential trading opportunities. Notable bullish sentiment was observed in NVDA, AMD, MARA, SMCI, GDDY, and IREN through call trades, while bearish sentiment was seen in AAPL, PLTR, and ENPH with put sweeps. ARM experienced a call sweep with bearish sentiment. The activity suggests varying investor expectations on these stocks' future movements.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:35 pm

UNP

Over the past 20 years, Union Pacific (NYSE:UNP) has produced an average annual return of 14.68%, outperforming the market by 7.09% annually. A $100 investment in UNP 20 years ago would now be worth $1,541.77. The company currently has a market capitalization of $150.06 billion.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:32 pm

QRTEA

Michael Burry has taken a new position in Qurate Retail, purchasing 600,000 shares, as revealed in a 13F filing.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 5:32 pm

NKE

Recent unusual options activity on Nike (NYSE:NKE) indicates a bullish stance by large investors, with a split sentiment of 52% bullish and 47% bearish. The activity includes 17 uncommon trades, with 8 puts and 9 calls, targeting a price range of $95.0 to $120.0. The volume and open interest trends suggest increased interest in Nike's options. The largest trades observed show a mix of bullish and bearish sentiments with varying expiration dates and strike prices. Nike, a leading athletic footwear and apparel brand, has seen its stock price slightly decrease by -0.55% to $104.42, with an upcoming earnings release in 34 days.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:31 pm

QCOM

Deep-pocketed investors have shown a bearish sentiment towards Qualcomm (NASDAQ:QCOM), with unusual options activity detected. The activity includes 29 notable options trades, with a bearish majority. The price range focus is between $130.0 and $200.0. Qualcomm's stock is currently up 0.89% at $151.38, with potential overbought signals. Analyst ratings are mixed, with a consensus target price of $159.0. Notable trades include bearish puts and bullish calls, with significant trade prices and volumes.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:31 pm

AXP

JAZZ

PEP

TLRY

Emily Paxhia, co-founder of Poseidon Investment Management, leverages her psychology background to analyze and invest in the cannabis industry. Poseidon, established in 2013, has successfully invested in major cannabis companies like Aphria (now part of Tilray Brands) and GW Pharmaceuticals (acquired by Jazz Pharmaceuticals). Paxhia's expertise has positioned Poseidon as a leader in cannabis investment, focusing on companies with strong market potential and recession-resistant products.

Portfolio Pulse from Nina Zdinjak

February 14, 2024 | 5:14 pm

MRNA

Deep-pocketed investors have shown a bullish sentiment towards Moderna (NASDAQ:MRNA), with options activity suggesting a price target between $70.0 and $160.0 in the next three months. Benzinga's tracking revealed 11 significant options activities, with a majority being bullish. The trading volume and open interest in Moderna's options have seen notable changes, indicating heightened investor interest. Moderna, a commercial-stage biotech, has its mRNA technology validated by the COVID-19 vaccine and is exploring various therapeutic areas.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:00 pm

CVNA

Deep-pocketed investors have shown unusual options activity in Carvana (NYSE:CVNA), with a bullish sentiment prevailing among 63% of them. The activity highlighted by Benzinga's options scanner includes 11 significant trades, with 7 calls totaling $512,414 and 4 puts at $173,756. These trades suggest a price target range for CVNA between $45.0 and $75.0 over the next three months. Currently, CVNA's stock is up 2.46% at $53.25, with an RSI indicating it may be approaching overbought territory. An analyst from JMP Securities has recently downgraded CVNA to Market Outperform with a price target of $60.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 4:45 pm